Table 2.

Effectiveness KD in Epilepsy condition.

S.No	KD Beneficial	KD Contraindications
1	Adenylosuccinate lyase deficiency64	Carnitine deficiency (primary)
2	CDKL5 encephalopathy	Carnitine palmitoyltransferase (CPT) I or II deficiency
3	Childhood absence epilepsy	Carnitine translocase deficiency
4	Cortical malformations	β-oxidation defects
5	Epilepsy of infancy with migrating focal seizures	Medium-chain acyl dehydrogenase deficiency (MCAD)
6	Epileptic encephalopathy with continuous spike-and-wave during sleep	Long-chain acyl dehydrogenase deficiency (LCAD)
7	Glycogenosis type V	Short-chain acyl dehydrogenase deficiency (SCAD)
8	Juvenile myoclonic epilepsy	Long-chain 3-hydroxyacyl-CoA deficiency
9	Lafora body disease	Medium-chain 3-hydroxyacyl-CoA deficiency.
10	Landau-Kleffner syndrome	Pyruvate carboxylase deficiency
11	Lennox-Gastaut syndrome	Porphyria
12	Phosphofructokinase deficiency	Inability to maintain adequate nutrition
13	Rett syndrome	Surgical focus identified by neuroimaging and video-EEG monitoring
14	Subacute sclerosing panencephalitis (SSPE)	Parent or caregiver noncompliance

Note: Data has been taken from Kossoff et al., 2018 [64].